Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10036413 | 1.00 | GAA (0.49) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL20662719 | 0.94 | GAA (0.44) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL9613609 | 0.94 | GAA (0.46) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL30209 | 0.91 | GAA (0.57) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL10297359 | 0.90 | GAA (0.41) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL12807224 | 0.90 | GAA (0.41) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL12031561 | 0.90 | GAA (0.41) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL12439523 | 0.89 | GAA (0.40) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL29923229 | 0.89 | GAA (0.56) | GAAKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL29764272 | 0.89 | GAA (0.56) | GAAKMT2AMEN1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024128240-A1 | RESIN COMPOSITION | 三菱瓦斯化学株式会社 | 2024-06-20 | — | — | WO | disclosed |
| EP-3688118-B1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2021-05-19 | — | — | EP | disclosed |
| EP-3757192-A1 | LIQUID CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2020-12-30 | — | — | EP | disclosed |
| US-20120327357-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL MEDIA AND LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-12-27 | — | — | US | disclosed |
| EP-2514800-A2 | Compounds and liquid crystalline medium | Merck Patent GmbH (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-2222816-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-10-17 | — | — | EP | disclosed |
| US-20120248374-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-10-04 | — | — | US | disclosed |
| WO-2012130380-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-10-04 | — | — | WO | disclosed |
| EP-2176376-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-09-19 | — | — | EP | disclosed |
| EP-2265691-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-08-29 | — | — | EP | disclosed |
| EP-1959000-A1 | Liquid crystalline medium | MERCK PATENT GmbH (DE) | 2008-08-20 | — | — | EP | disclosed |
| EP-1956069-A1 | Liquid crystalline medium | Merck Patent GmbH (DE) | 2008-08-13 | — | — | EP | disclosed |
| EP-1935963-A1 | Liquid-crystalline medium | Merck Patent GmbH (DE) | 2008-06-25 | — | — | EP | disclosed |
| US-20080121843-A1 | Liquid crystals having a terminal polar radical and a terminal CH3 group and simultaneously having very high specific resistances and low threshold voltages requiring a high clearing point and low rotational viscosity; matrices | HECKMEIER MICHAEL | 2008-05-29 | — | — | US | disclosed |
| US-7371437-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2008-05-13 | — | — | US | disclosed |
| US-7361288-B2 | Components for high-frequency technology | MERCK PATENT GESELLSCHAFT MIT BESSCHRANKTER HAFTUNG (DE) | 2008-04-22 | — | — | US | disclosed |
| EP-1746079-B1 | Fluorinated biphenyl compounds for use in liquid crystal compositions | MERCK PATENT GMBH (DE) | 2008-03-26 | — | — | EP | disclosed |
| WO-2008009417-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2008-01-24 | — | — | WO | disclosed |
| WO-2008009398-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2008-01-24 | — | — | WO | disclosed |
| EP-1876214-A2 | Liquid crystalline medium | Merck Patent GmbH (DE) | 2008-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120248374-A1 | LIQUID CRYSTALLINE MEDIUM | LBR, CTNND1, VIM | GAA 3873/4885KMT2A 4403/4885MEN1 663/4885 |
| US-20120327357-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL MEDIA AND LIQUID-CRYSTAL DISPLAYS | LPXN, VCL, MAP1LC3C | GAA 3851/4885KMT2A 3584/4885MEN1 1184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.